Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AnaptysBio, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ANAB
Nasdaq
2830
www.anaptysbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AnaptysBio, Inc.
AnaptysBio (ANAB) vs. PTCT and MIRM: Is the Market Missing the Value of Its Royalty Stream and Legal Upside?
- Oct 31st, 2026 3:17 pm
Is AnaptysBio (ANAB) Undervalued Following Jemperli's Early FDA Approval?
- Oct 30th, 2026 1:10 am
Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings Growth
- Oct 28th, 2026 7:00 am
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
- Oct 27th, 2026 7:00 am
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
- Oct 19th, 2026 12:18 pm
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged
- Oct 12th, 2026 2:10 pm
AnaptysBio (ANAB) Could Be 49% Undervalued On Its Royalty Story
- Oct 8th, 2026 10:29 pm
AnaptysBio (ANAB) Stock Looks Undervalued Even After A 273% Rise
- Oct 8th, 2026 5:17 pm
AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance
- Sep 26th, 2026 8:11 am
AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns?
- Sep 25th, 2026 9:38 pm
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
- Sep 21st, 2026 3:35 pm
Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update
- Sep 21st, 2026 2:15 pm
Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB)
- Sep 14th, 2026 12:34 pm
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
- Sep 1st, 2026 2:15 pm
GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control
- Aug 17th, 2026 9:03 am
What Makes AnaptysBio (ANAB) an Investment Bet?
- Jul 14th, 2026 8:56 am
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
- May 21st, 2026 7:40 am
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?
- May 19th, 2026 7:55 am
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets
- May 15th, 2026 8:18 am
AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- May 14th, 2026 7:55 am
Scroll